CYTOKINETICS INC — Director's Dealing 2021

Nov 20, 2021

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: CYTOKINETICS INC (CYTK)
CIK: 0001061983
Period of Report: 2021-11-19

Reporting Person: SMITH SANDFORD D (Director)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2021-11-19	Common Stock	M	5000	$9.45	Acquired	11765	Direct
2021-11-19	Common Stock	S	5000	$41.2054	Disposed	6765	Direct
2021-11-19	Common Stock	M	20000	$14.25	Acquired	26765	Direct
2021-11-19	Common Stock	S	20000	$41.2054	Disposed	6765	Direct
2021-11-19	Common Stock	M	4032	$12.4	Acquired	10797	Direct
2021-11-19	Common Stock	S	4032	$41.2054	Disposed	6765	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2021-11-19	Non-Qualified Stock Option (right to buy)	$9.45	M	5000	Disposed	2028-05-16	Common Stock (5000)	Direct
2021-11-19	Non-Qualified Stock Option (right to buy)	$12.4	M	4032	Disposed	2027-01-03	Common Stock (4032)	Direct
2021-11-19	Non-Qualified Stock Option (right to buy)	$14.25	M	20000	Disposed	2027-05-18	Common Stock (20000)	Direct

Footnotes

F1: Amount includes 1,765 shares of common stock received at Reporting Person's election pursuant Issuer's stock in lieu of cash for all or part of directors' annual base retainer program.